194 related articles for article (PubMed ID: 10777615)
21. Replacement of the positively charged Walker A lysine residue with a hydrophobic leucine residue and conformational alterations caused by this mutation in MRP1 impair ATP binding and hydrolysis.
Buyse F; Hou YX; Vigano C; Zhao Q; Ruysschaert JM; Chang XB
Biochem J; 2006 Jul; 397(1):121-30. PubMed ID: 16551273
[TBL] [Abstract][Full Text] [Related]
22. Expression and function of human MRP1 (ABCC1) is dependent on amino acids in cytoplasmic loop 5 and its interface with nucleotide binding domain 2.
Iram SH; Cole SP
J Biol Chem; 2011 Mar; 286(9):7202-13. PubMed ID: 21177244
[TBL] [Abstract][Full Text] [Related]
23. Functional importance of three basic residues clustered at the cytosolic interface of transmembrane helix 15 in the multidrug and organic anion transporter MRP1 (ABCC1).
Conseil G; Deeley RG; Cole SP
J Biol Chem; 2006 Jan; 281(1):43-50. PubMed ID: 16230346
[TBL] [Abstract][Full Text] [Related]
24. Nucleotide binding and nucleotide hydrolysis properties of the ABC transporter MRP6 (ABCC6).
Cai J; Daoud R; Alqawi O; Georges E; Pelletier J; Gros P
Biochemistry; 2002 Jun; 41(25):8058-67. PubMed ID: 12069597
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterization of functionally important elements in the multidrug resistance protein 1 COOH-terminal region.
Westlake CJ; Payen L; Gao M; Cole SP; Deeley RG
J Biol Chem; 2004 Dec; 279(51):53571-83. PubMed ID: 15459206
[TBL] [Abstract][Full Text] [Related]
26. Mutations in either nucleotide-binding site of P-glycoprotein (Mdr3) prevent vanadate trapping of nucleotide at both sites.
Urbatsch IL; Beaudet L; Carrier I; Gros P
Biochemistry; 1998 Mar; 37(13):4592-602. PubMed ID: 9521779
[TBL] [Abstract][Full Text] [Related]
27. Interaction between the bound Mg.ATP and the Walker A serine residue in NBD2 of multidrug resistance-associated protein MRP1 plays a crucial role for the ATP-dependent leukotriene C4 transport.
Yang R; Scavetta R; Chang XB
Biochemistry; 2008 Aug; 47(32):8456-64. PubMed ID: 18636743
[TBL] [Abstract][Full Text] [Related]
28. The "LSGGQ" motif in each nucleotide-binding domain of human P-glycoprotein is adjacent to the opposing walker A sequence.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2002 Nov; 277(44):41303-6. PubMed ID: 12226074
[TBL] [Abstract][Full Text] [Related]
29. Properties of P-glycoprotein with mutations in the "catalytic carboxylate" glutamate residues.
Tombline G; Bartholomew LA; Tyndall GA; Gimi K; Urbatsch IL; Senior AE
J Biol Chem; 2004 Nov; 279(45):46518-26. PubMed ID: 15326176
[TBL] [Abstract][Full Text] [Related]
30. Multiple membrane-associated tryptophan residues contribute to the transport activity and substrate specificity of the human multidrug resistance protein, MRP1.
Koike K; Oleschuk CJ; Haimeur A; Olsen SL; Deeley RG; Cole SP
J Biol Chem; 2002 Dec; 277(51):49495-503. PubMed ID: 12388549
[TBL] [Abstract][Full Text] [Related]
31. Drug-stimulated ATPase activity of human P-glycoprotein is blocked by disulfide cross-linking between the nucleotide-binding sites.
Loo TW; Clarke DM
J Biol Chem; 2000 Jun; 275(26):19435-8. PubMed ID: 10806188
[TBL] [Abstract][Full Text] [Related]
32. Evidence for the vectorial nature of drug (substrate)-stimulated ATP hydrolysis by human P-glycoprotein.
Sauna ZE; Smith MM; Müller M; Ambudkar SV
J Biol Chem; 2001 Sep; 276(36):33301-4. PubMed ID: 11451943
[TBL] [Abstract][Full Text] [Related]
33. Functional asymmetry of the two nucleotide binding domains in the ABC transporter Ste6.
Proff C; Kölling R
Mol Gen Genet; 2001 Feb; 264(6):883-93. PubMed ID: 11254136
[TBL] [Abstract][Full Text] [Related]
34. The Walker B motif of the second nucleotide-binding domain (NBD2) of CFTR plays a key role in ATPase activity by the NBD1-NBD2 heterodimer.
Stratford FL; Ramjeesingh M; Cheung JC; Huan LJ; Bear CE
Biochem J; 2007 Jan; 401(2):581-6. PubMed ID: 16989640
[TBL] [Abstract][Full Text] [Related]
35. Analysis of catalytic carboxylate mutants E552Q and E1197Q suggests asymmetric ATP hydrolysis by the two nucleotide-binding domains of P-glycoprotein.
Carrier I; Julien M; Gros P
Biochemistry; 2003 Nov; 42(44):12875-85. PubMed ID: 14596601
[TBL] [Abstract][Full Text] [Related]
36. Biochemical characterization and NMR studies of the nucleotide-binding domain 1 of multidrug-resistance-associated protein 1: evidence for interaction between ATP and Trp653.
Ramaen O; Masscheleyn S; Duffieux F; Pamlard O; Oberkampf M; Lallemand JY; Stoven V; Jacquet E
Biochem J; 2003 Dec; 376(Pt 3):749-56. PubMed ID: 12954082
[TBL] [Abstract][Full Text] [Related]
37. Nucleotide dissociation from NBD1 promotes solute transport by MRP1.
Yang R; McBride A; Hou YX; Goldberg A; Chang XB
Biochim Biophys Acta; 2005 Mar; 1668(2):248-61. PubMed ID: 15737336
[TBL] [Abstract][Full Text] [Related]
38. Tandem function of nucleotide binding domains confers competence to sulfonylurea receptor in gating ATP-sensitive K+ channels.
Zingman LV; Hodgson DM; Bienengraeber M; Karger AB; Kathmann EC; Alekseev AE; Terzic A
J Biol Chem; 2002 Apr; 277(16):14206-10. PubMed ID: 11825892
[TBL] [Abstract][Full Text] [Related]
39. Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids.
Leslie EM; Mao Q; Oleschuk CJ; Deeley RG; Cole SP
Mol Pharmacol; 2001 May; 59(5):1171-80. PubMed ID: 11306701
[TBL] [Abstract][Full Text] [Related]
40. Functional dissection of P-glycoprotein nucleotide-binding domains in chimeric and mutant proteins. Modulation of drug resistance profiles.
Beaudet L; Gros P
J Biol Chem; 1995 Jul; 270(29):17159-70. PubMed ID: 7615512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
